Literature DB >> 26022375

Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks.

Minoru Tagawa1, Sachie Ochiai1, Yuichi Nakamura1, Akinori Sato2, Masaomi Chinushi3.   

Abstract

A 73-year-old woman first visited our emergency room with multiple syncopal attacks. Before admission, she had received an antibiotic (Garenoxacin) for 3 days from a local clinic. First electrocardiogram (ECG) showed no ST-segment deviation but mild QT interval prolongation with a positive U wave. Second ECG recording 3 h later showed slightly slower heart rate and revealed marked QTU interval prolongation suggesting the cause of her syncopal attacks. After cessation of Garenoxacin, the QTU interval prolongation shortened. However, both epinephrine infusion and treadmill exercise test reproduced similar QTU interval prolongation and T wave deformities. Later, genetic analysis demonstrated that this patient had a mutation in KCNH2 gene, and she was diagnosed as a type-2 long-QT syndrome which was accentuated by use of garenoxacin. At the emergency out-patient clinic, repetitive ECG recordings can be useful and should be considered in order to identify the cause of syncopal attacks in patients who were prescribed antibiotics and had mild QT interval abnormalities.

Entities:  

Keywords:  Garenoxacin; Long-QT syndrome; Syncope

Mesh:

Substances:

Year:  2015        PMID: 26022375     DOI: 10.1007/s00380-015-0693-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

1.  A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers.

Authors:  Naoki Toyota; Aya Miyazaki; Heima Sakaguchi; Wataru Shimizu; Hideo Ohuchi
Journal:  Heart Vessels       Date:  2014-06-11       Impact factor: 2.037

2.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

3.  Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome.

Authors:  Wataru Shimizu; Takashi Noda; Hiroshi Takaki; Noritoshi Nagaya; Kazuhiro Satomi; Takashi Kurita; Kazuhiro Suyama; Naohiko Aihara; Kenji Sunagawa; Shigeyuki Echigo; Yoshihiro Miyamoto; Yasunao Yoshimasa; Kazufumi Nakamura; Tohru Ohe; Jeffrey A Towbin; Silvia G Priori; Shiro Kamakura
Journal:  Heart Rhythm       Date:  2004-09       Impact factor: 6.343

4.  Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.

Authors:  Arthur J Moss; Wojciech Zareba; Elizabeth S Kaufman; Eric Gartman; Derick R Peterson; Jesaia Benhorin; Jeffrey A Towbin; Mark T Keating; Silvia G Priori; Peter J Schwartz; G Michael Vincent; Jennifer L Robinson; Mark L Andrews; Changyong Feng; W Jackson Hall; Aharon Medina; Li Zhang; Zhiqing Wang
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

5.  Genotype-phenotype aspects of type 2 long QT syndrome.

Authors:  Wataru Shimizu; Arthur J Moss; Arthur A M Wilde; Jeffrey A Towbin; Michael J Ackerman; Craig T January; David J Tester; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Elizabeth S Kaufman; Nynke Hofman; Takashi Noda; Shiro Kamakura; Yoshihiro Miyamoto; Samit Shah; Vinit Amin; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

Review 6.  Long QT syndrome.

Authors:  Ilan Goldenberg; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2008-06-17       Impact factor: 24.094

7.  Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.

Authors:  Jorge A Wong; Lorne J Gula; George J Klein; Raymond Yee; Allan C Skanes; Andrew D Krahn
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-01-09

8.  Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome.

Authors:  Peter J Schwartz; Emilio Vanoli; Lia Crotti; Carla Spazzolini; Chiara Ferrandi; Althea Goosen; Paula Hedley; Marshall Heradien; Sara Bacchini; Annalisa Turco; Maria Teresa La Rovere; Antonella Bartoli; Alfred L George; Paul A Brink
Journal:  J Am Coll Cardiol       Date:  2008-03-04       Impact factor: 24.094

9.  Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.

Authors:  Anton Mihic; Vijay S Chauhan; Xiaodong Gao; Gavin Y Oudit; Robert G Tsushima
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

10.  The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndrome.

Authors:  Sally-Ann B Clur; Priya Chockalingam; Luc H Filippini; Ari P Widyanti; Marc Van Cruijsen; Nico A Blom; Mariel Alders; Nynke Hofman; Arthur A M Wilde
Journal:  Pediatr Cardiol       Date:  2009-12-03       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.